Oracle Shares Gain Analyst Favor Amid Strategic Clarity
26.02.2026 - 14:22:20 | boerse-global.deAfter facing months of skepticism, Oracle is receiving renewed support from the analyst community. The catalyst is an upgraded rating from Oppenheimer, which highlights a shifting risk-reward perspective following a significant share price decline. This change in sentiment raises questions about the underlying drivers for the reassessment.
Clarifying the Financial and Partnership Landscape
A key factor in the upgraded outlook is the perceived reduction of concerns surrounding OpenAI, a major partner. Oppenheimer pointed to OpenAI's reported recovery to over 800 million weekly users by early February 2026. Furthermore, the establishment of OpenAI's first dedicated enterprise sales division and expectations for a funding round of approximately $100 billion have alleviated fears about its ability to meet substantial data center commitments with Oracle.
Concurrently, Oracle is providing more detail on how it intends to finance its massive expansion in AI and cloud infrastructure. Oppenheimer estimates that investments nearing $330 billion could be required by fiscal 2030. In response, Oracle announced on February 1 its intention to raise $45 to $50 billion gross in calendar year 2026. This strategy involves up to $20 billion in equity, raised through mandatory convertible preferred instruments and an at-the-market program, complemented by a single investment-grade senior unsecured bond issuance early in the year. The company has enlisted Goldman Sachs to manage the debt offering and Citigroup for the equity measures, emphasizing its commitment to maintaining an investment-grade credit rating.
The Rationale Behind Oppenheimer's Revised Outlook
Oppenheimer analyst Brian Schwartz elevated his rating on Oracle from "Perform" to "Outperform," assigning a price target of $185. His core argument centers on valuation: the prolonged sell-off since last autumn has compressed Oracle's price-to-earnings multiple considerably. According to data cited by Invezz, the stock now trades at roughly 19 times expected earnings, a stark contrast to the multiple exceeding 40 observed in September.
Schwartz also characterized Oracle as a robust "EPS compounder," a company with a reliable track record of increasing its earnings per share over extended periods. He outlined to CNBC scenarios where, by fiscal 2030, the company's EPS could potentially double or even triple from current levels.
Understanding the Previous Market Pressure
The downward pressure on Oracle's stock since September originated from several investor concerns. One significant issue was the concentration of a large portion of its remaining performance obligations (RPO) with OpenAI. This concentration sparked worries about single-party risk and the long-term financial durability of this key counterparty.
Should investors sell immediately? Or is it worth buying Oracle?
Uncertainty regarding the funding strategy for Oracle's aggressive AI and cloud data center build-out further weighed on sentiment. This overhang was powerful enough to overshadow strong operational results. For instance, following the release of its Q2 fiscal 2026 report on December 11, 2025, Oracle's shares fell 10.8% in a single session. The decline occurred despite the company posting adjusted earnings per share of $2.26 (a 54% increase) and revenue of $16.1 billion (up 14%), as reported by Barchart. Within those results, cloud revenue grew 34% to $8 billion.
Current Performance and Forthcoming Catalyst
The stock's recent performance continues to reflect challenges. Over the past 30 days, shares have declined by 13.80%, and year-to-date, the loss stands at 24.98%, indicating persistent pressure.
The market's next major checkpoint will be Oracle's quarterly report, expected on March 9, 2026. This update is anticipated to provide evidence on whether the company's substantial investments are effectively translating into accelerated growth and if the newly outlined capital plan is progressing as smoothly as management has projected.
Ad
Oracle Stock: New Analysis - 26 February
Fresh Oracle information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
So schätzen die Börsenprofis Oracle Aktien ein!
Für. Immer. Kostenlos.

